Cargando…
Safety & effectiveness of COVID-19 vaccines: A narrative review
There are currently eight vaccines against SARS-CoV-2 that have received Emergency Use Authorization by the WHO that can offer some protection to the world’s population during the COVID-19 pandemic. Though research is being published all over the world, public health officials, policymakers and gove...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552389/ https://www.ncbi.nlm.nih.gov/pubmed/35859436 http://dx.doi.org/10.4103/ijmr.IJMR_474_21 |
_version_ | 1784806240199639040 |
---|---|
author | Chirico, Francesco da Silva, Jaime A. Teixeira Tsigaris, Panagiotis Sharun, Khan |
author_facet | Chirico, Francesco da Silva, Jaime A. Teixeira Tsigaris, Panagiotis Sharun, Khan |
author_sort | Chirico, Francesco |
collection | PubMed |
description | There are currently eight vaccines against SARS-CoV-2 that have received Emergency Use Authorization by the WHO that can offer some protection to the world’s population during the COVID-19 pandemic. Though research is being published all over the world, public health officials, policymakers and governments are collecting evidence-based information to establish the public health policies. Unfortunately, continued international travel, violations of lockdowns and social distancing, the lack of mask use, the emergence of mutant strains of the virus and lower adherence by a sector of the global population that remains sceptical of the protection offered by vaccines, or about any risks associated with vaccines, hamper these efforts. Here we examine the literature on the efficacy, effectiveness and safety of COVID-19 vaccines, with an emphasis on select categories of individuals and against new SARS-CoV-2 strains. The literature shows that these eight vaccines are highly effective in protecting the population from severe disease and death, but there are some issues concerning safety and adverse effects. Further, booster shots and variant-specific vaccines would also be required. |
format | Online Article Text |
id | pubmed-9552389 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-95523892022-10-12 Safety & effectiveness of COVID-19 vaccines: A narrative review Chirico, Francesco da Silva, Jaime A. Teixeira Tsigaris, Panagiotis Sharun, Khan Indian J Med Res Review Article There are currently eight vaccines against SARS-CoV-2 that have received Emergency Use Authorization by the WHO that can offer some protection to the world’s population during the COVID-19 pandemic. Though research is being published all over the world, public health officials, policymakers and governments are collecting evidence-based information to establish the public health policies. Unfortunately, continued international travel, violations of lockdowns and social distancing, the lack of mask use, the emergence of mutant strains of the virus and lower adherence by a sector of the global population that remains sceptical of the protection offered by vaccines, or about any risks associated with vaccines, hamper these efforts. Here we examine the literature on the efficacy, effectiveness and safety of COVID-19 vaccines, with an emphasis on select categories of individuals and against new SARS-CoV-2 strains. The literature shows that these eight vaccines are highly effective in protecting the population from severe disease and death, but there are some issues concerning safety and adverse effects. Further, booster shots and variant-specific vaccines would also be required. Wolters Kluwer - Medknow 2022-01 /pmc/articles/PMC9552389/ /pubmed/35859436 http://dx.doi.org/10.4103/ijmr.IJMR_474_21 Text en Copyright: © 2022 Indian Journal of Medical Research https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Review Article Chirico, Francesco da Silva, Jaime A. Teixeira Tsigaris, Panagiotis Sharun, Khan Safety & effectiveness of COVID-19 vaccines: A narrative review |
title | Safety & effectiveness of COVID-19 vaccines: A narrative review |
title_full | Safety & effectiveness of COVID-19 vaccines: A narrative review |
title_fullStr | Safety & effectiveness of COVID-19 vaccines: A narrative review |
title_full_unstemmed | Safety & effectiveness of COVID-19 vaccines: A narrative review |
title_short | Safety & effectiveness of COVID-19 vaccines: A narrative review |
title_sort | safety & effectiveness of covid-19 vaccines: a narrative review |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552389/ https://www.ncbi.nlm.nih.gov/pubmed/35859436 http://dx.doi.org/10.4103/ijmr.IJMR_474_21 |
work_keys_str_mv | AT chiricofrancesco safetyeffectivenessofcovid19vaccinesanarrativereview AT dasilvajaimeateixeira safetyeffectivenessofcovid19vaccinesanarrativereview AT tsigarispanagiotis safetyeffectivenessofcovid19vaccinesanarrativereview AT sharunkhan safetyeffectivenessofcovid19vaccinesanarrativereview |